Bluejay Therapeutics announced it raised $20.5 Million in an initial filing from an offering of $41.2 Million

Aug 16, 2022•almost 3 years ago

Amount Raised

$20.5 Million

San MateoInformation Technology

Company Information

Company

Bluejay Therapeutics

Location

951 Mariners Island Blvd., Suite 300

San Mateo, California, United States

About

The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Bluejay Therapeutics announced it raised $20.5 Million in an initial filing from an offering of $41.2 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information